29 The impact of teicoplanin in prevention of implantable cardiac electrical devices infection. A single centre quality improvement audit
RB Pharithi(St. Vincent's University Hospital), John P. Erwin(NorthShore University HealthSystem), Michael Omar(St. Vincent's University Hospital), Laura Murphy(Brigham and Women's Hospital), Shani Morad(St. Vincent's University Hospital), Mark Hensey(St. Vincent's University Hospital), Dermot O’Hare(University of Oxford), Farooq Azam Rathore(Bolan University of Medical and Health Sciences), Diarmaid Cadogan(Mater Misericordiae University Hospital), Cindy McCreery(St. Vincent's University Hospital), Patricia M. Flynn(St. Jude Children's Research Hospital), S Mubarak(St. Vincent's University Hospital), Martin Quinn(St. Vincent's University Hospital)
Cited by 0
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
|Nature Medicine|1999|580
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
|New England Journal of Medicine|2016|348